Should oxyhaemoglobin saturation be monitored continuously during the 6-minute walk test?

Abstract

Guidelines for conducting the 6-minute walk test (6MWT) indicate that oxyhaemoglobin saturation (SpO₂) should not be monitored constantly during the test. The aim of this study was to determine whether the nadir SpO₂ differs from the end-6MWT SpO₂ in patients with chronic respiratory disease. A total of 86 subjects underwent the 6MWT according to a standardized protocol with continuous monitoring of SpO₂ by pulse oximeter. Comparison of nadir SpO₂ and end SpO₂ was made and the proportion of subjects with important desaturation according to each measure was determined. The effect of resting during the 6MWT on the likelihood of a significant difference between nadir and end SpO₂ was evaluated. A total of 29 subjects with chronic obstructive pulmonary disease (COPD; mean [SD] forced expiratory volume in 1 second [FEV₁] 51[21] % predicted) and 57 with interstitial lung disease (ILD; TLCO 49[18] % predicted) were studied. Nadir SpO₂ was slightly lower than end-test SpO₂ (median 87% vs. 88%, p < 0.001) with differences ranging from 1% to 10%. Those who rested during the test (n = 14) were more likely to have a significant difference between nadir SpO₂ and end SpO₂ (p = 0.04). End SpO₂ did not accurately identify desaturation in 21% of subjects. No differences between COPD and ILD were observed. For most patients with chronic respiratory disease, the end SpO₂ and the nadir SpO₂ are similar during the 6MWT. However, the end SpO₂ does not give an accurate estimate of nadir SpO₂ in patients who rest. Consideration should be given to the constant monitoring of SpO₂ during the 6MWT.

Keywords

exercise test pulmonary disease chronic obstructive pulmonary fibrosis

References

ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.

Enright PL The six-minute walk test. Respir Care 2003 ; 48: 783-785.

Casanova C. , Cote C. , Marin JM , et al. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 2008; 134: 746-752.

Lama VN , Flaherty KR , Toews GB , Colby TV , Travis WD , Long Q. , et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 1084-1090.

Jubran A. Pulse oximetry. Crit Care 1999; 3: R11-R17.

Chatterjee AB , Rissmiller RW , Meade K. , and Paladenech C. Reproducibility of the 6-minute walk test for ambulatory oxygen prescription. Respiration 2010; 79: 121-127.

Poulain M. , Durand F. , Palomba B. , Ceugniet F. , Desplan J. , Varray A. , et al. 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest 2003; 123: 1401-1407.